SCHEMBL29867704

SCHEMBL29867704

Cc1cc(O)cc(C2(CF)CC2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275728 0.67 — —
SCHEMBL22549094 0.64 MAPK1 (0.31) —
SCHEMBL29577064 0.61 — —
SCHEMBL502316 0.61 — —
SCHEMBL6675970 0.59 NOS3 (0.42) —
SCHEMBL31266597 0.58 — —
SCHEMBL26601677 0.58 — —
SCHEMBL8608711 0.58 — —
SCHEMBL8351556 0.58 — —
SCHEMBL24425440 0.58 SLC6A3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024032615-A1 CRYSTAL FORM OF PYRIDINOPYRIMIDINONE COMPOUND, ACID SALT THEREOF, CRYSTAL FORM OF ACID SALT THEREOF, AND USE 武汉人福创新药物研发中心有限公司 2024-02-15 — — WO disclosed
CN-117534667-A Crystal forms of pyridopyrimidinone compound, acid salts thereof, crystal forms of acid salts thereof and use 武汉人福创新药物研发中心有限公司 2024-02-09 — — CN disclosed
WO-2024008185-A1 PHARMACEUTICAL COMPOSITION CONTAINING SOS1 INHIBITOR 武汉人福创新药物研发中心有限公司 2024-01-11 — — WO disclosed
CN-117357650-A Pharmaceutical composition comprising SOS1 inhibitor 武汉人福创新药物研发中心有限公司 2024-01-09 — — CN disclosed
CN-114907341-A Pyridopyrimidinone derivatives, and preparation method and application thereof 武汉人福创新药物研发中心有限公司 2022-08-16 — — CN disclosed
WO-2022166974-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-08-11 — — WO disclosed
Send feedback